Latest Female sexual arousal disorder Stories
ALMERE, the Netherlands, April 17, 2015 /PRNewswire/ -- Emotional Brain, an innovative Dutch company that is developing two drugs for sexual dysfunction in women, is pleased
Coalition highlights momentum behind campaign for approval of first-ever drug for women's sexual dysfunction, launches new website for supporters to contact their elected representatives
CRANBURY, N.J., Feb. 20, 2015 /PRNewswire/ -- Palatin Technologies, Inc.
RALEIGH, N.C., Feb. 17, 2015 /PRNewswire/ -- Sprout Pharmaceuticals announced today that it has resubmitted a New Drug Application (NDA) to the U.S.
Triggers euro 2.5 Million (~$3 Million) Milestone Payment from Gedeon Richter CRANBURY, N.J., Dec. 29, 2014 /PRNewswire/ -- Palatin Technologies, Inc.
Survey Results Released After the FDA's First Drug Development Public Workshop on Female Sexual Dysfunction RED BANK, N.J., Nov.
Even the Score Campaign Calls on FDA to Approve Medical Treatment Options for Female Sexual Dysfunction WASHINGTON, Oct.
Group Highlights Benefits Of FDA-Approved Treatment Options For Quality Of Relationships As FDA Prepares For Landmark Workshop On FSD WASHINGTON, Oct.
CRANBURY, N.J. and BUDAPEST, Hungary, Sept. 3, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN; hereinafter: "Palatin") and Gedeon Richter Plc.
Persistent gender inequity at FDA has led to 26 approved drugs for men, and ZERO for women WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- Highlighting a persistent gender inequity at the
- An armed gangster.